A "refill" of Pear Therapeutics’ reSET-O digital prescription therapeutic for treating opioid use disorder is associated with high levels of abstinence and treatment retention as well as fewer hospital encounters, according to a study published in Hospital Practice.
Most of the study’s authors are current or former Pear employees.
TOP-LINE DATA
Out of a group of 3,817 people who completed a 12-...
Pear Therapeutics’ reSET-O prescription digital therapeutic for opioid use disorder lowered healthcare costs and added quality life years post-treatment, according to a Pear-funded analysis published in the Journal of Market Access & Health Policy.
TOP-LINE DATA
Over 12 weeks, using reSET-O in addition to treatment as usual lowered costs by $1,014 and added 0.003 quality-adjusted life years...
About the authors: Dr. Sofia Noori (@sofianoori) was a member of the 2019 Flare Capital Partners Scholar Class and is currently a psychiatry resident at Yale School of Medicine. She is the curriculum lead for Innovation to Impact, a substance use entrepreneurship program funded by the National Institute for Drug Abuse.
Dr. Dan Gebremedhin (@dangebremedhin) is a partner at Flare Capital Partners...
Looking to the opioid use disorder space the National Institutes of Health has given Roundtrip, a software platform for organizing medical transport, a $252,000 Small Business Innovation Research (SBIR) Phase I grant in order to look at the impact of transportation on OUD treatment.
Specifically, the study will be zeroing in on appointment show-rates and patient experiences. Roundtrip, the...
Having a baby can be complicated and requires regular doctors visits and classes. Mix those challenges with managing a substance abuse disorder, and the result can be overwhelming.
iTether Technologies and University of Arizona physician Dr. Maria Manriquez have teamed up to develop a new app specifically designed to address the needs of pregnant women who are also dealing with opioid addiction...
At HIMSS19, telehealth platform company American Well unveiled the American Well 250 cart, a telehealth cart that allows physicians and patients in a hospital to connect to a wide range of specialists. The product is the first fruit of American Well’s acquisition of Avizia in April of last year.
Additionally at the show, American Well announced an expanded partnership with behavioral health-...
Yesterday morning addiction-focused telemedicine company Workit Health announced a new Series A funding round led by Blue Cross Blue Shield Venture Partners for an undisclosed amount. Other funders include Endeavor Catalyst, Montage Ventures, Lux Capital, Wakestream Ventures, Invest Detroit and RRE Ventures.
This marks the second funding round for the Californian startup. Originally founded in...
This morning San Francisco-based telemedicine platform HeyDoctor announced that its customers will now be able to receive naloxone, including Narcan, through its website and mobile app.
Users will first go through a text chat-based consultation with a physician on HeyDoctor about how and when to use the medication, which can reverse the effects of an opioid overdose. The prescription can then be...
The victors of two Robert Wood Johnson Foundation (RWJF) pitch competitions were recently announced following a live judging session held at Health 2.0 in Santa Clara, California. There, judges named Buoy Health’s chatbot for patient health education the winner of RWJF’s AI Challenge, while social addiction support platform Sober Grid claimed first prize in the organization’s Opioid Challenge....
Following in the footsteps of its parent company, Instagram is looking reduce its potential role in the ongoing opioid epidemic.
Whenever a user searches a drug or substance-related term on the platform, they will now be served a popup that includes a link to addiction and drug misuse resources. Should users click through the popup alert, Instagram redirects to a webpage asking users whether they...
